These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35011842)

  • 1. Cognitive Impairement in Non-Cirrhotic Portal Hypertension: Highlights on Physiopathology, Diagnosis and Management.
    Gioia S; Nardelli S; Riggio O; Faccioli J; Ridola L
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors.
    Nicoletti V; Gioia S; Lucatelli P; Nardelli S; Pasquale C; Nogas Sobrinho S; Pentassuglio I; Greco F; De Santis A; Merli M; Riggio O
    Dig Liver Dis; 2016 Sep; 48(9):1072-7. PubMed ID: 27448844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes and Management of Non-cirrhotic Portal Hypertension​.
    Gioia S; Nardelli S; Ridola L; Riggio O
    Curr Gastroenterol Rep; 2020 Sep; 22(12):56. PubMed ID: 32940785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease.
    Nicoară-Farcău O; Rusu I; Stefănescu H; Tanțău M; Badea RI; Procopeț B
    World J Gastroenterol; 2020 Jun; 26(22):3000-3011. PubMed ID: 32587444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Patients at High Risk of Developing Non-Cirrhotic Portal Hypertension.
    Gioia S; Riggio O; Nardelli S; d'Amati G; Ridola L
    Hepat Med; 2021; 13():105-111. PubMed ID: 34764704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.
    Franzoni Lde C; de Carvalho FC; Garzon RG; Yamashiro Fda S; Augusti L; Santos LA; Dorna Mde S; Baima JP; Lima TB; Caramori CA; Silva GF; Romeiro FG
    World J Gastroenterol; 2014 Nov; 20(42):15910-5. PubMed ID: 25400477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological abnormalities in splenic vasculature in non-cirrhotic portal hypertension: Its relevance in the management of portal hypertension.
    Gupta S; Pottakkat B; Verma SK; Kalayarasan R; Chandrasekar A S; Pillai AA
    World J Gastrointest Surg; 2020 Jan; 12(1):1-8. PubMed ID: 31984119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of influencing factors on hepatic encephalopathy in patients with non-cirrhotic portal hypertension].
    Liu M; He WT; Chen DS; Hu DH
    Zhonghua Gan Zang Bing Za Zhi; 2019 Sep; 27(9):673-676. PubMed ID: 31594090
    [No Abstract]   [Full Text] [Related]  

  • 9. Portal vein thrombosis, hepatic decompensation, and survival in patients with porto-sinusoidal vascular disease and portal hypertension.
    Zhang X; Durham KM; Garza AA; Murali AR
    J Gastroenterol; 2023 Mar; 58(3):268-276. PubMed ID: 36692825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porto-sinusoidal vascular disease: proposal and description of a novel entity.
    De Gottardi A; Rautou PE; Schouten J; Rubbia-Brandt L; Leebeek F; Trebicka J; Murad SD; Vilgrain V; Hernandez-Gea V; Nery F; Plessier A; Berzigotti A; Bioulac-Sage P; Primignani M; Semela D; Elkrief L; Bedossa P; Valla D; Garcia-Pagan JC;
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):399-411. PubMed ID: 30957754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune biomarkers in porto-sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology.
    Cerda Reyes E; González-Navarro EA; Magaz M; Muñoz-Sánchez G; Diaz A; Silva-Junior G; Triguero A; Lafoz E; Campreciós G; Orts L; Perez-Campuzano V; Seijo S; Rubio L; Turon F; Baiges A; Hernández-Gea V; Álvarez-Larran A; Juan M; Garcia-Pagan JC
    Liver Int; 2021 Sep; 41(9):2171-2178. PubMed ID: 34173316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-cirrhotic portal hypertension versus idiopathic portal hypertension.
    Okuda K
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S204-13. PubMed ID: 12472938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder.
    Lampichler K; Semmler G; Wöran K; Simbrunner B; Jachs M; Hartl L; Bauer DJM; Balcar L; Burghart L; Trauner M; Tamandl D; Ba-Ssalamah A; Mandorfer M; Reiberger T; Scheiner B; Scharitzer M
    Eur Radiol; 2023 Feb; 33(2):1422-1432. PubMed ID: 36166087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiological Intervention for Shunt Related Encephalopathy.
    Nardelli S; Gioia S; Ridola L; Riggio O
    J Clin Exp Hepatol; 2018 Dec; 8(4):452-459. PubMed ID: 30564003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porto-sinusoidal vascular disorder.
    De Gottardi A; Sempoux C; Berzigotti A
    J Hepatol; 2022 Oct; 77(4):1124-1135. PubMed ID: 35690264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt.
    Trevisani F; Merli M; Savelli F; Valeriano V; Zambruni A; Riggio O; Caraceni P; Domenicali M; Bernardi M
    J Hepatol; 2003 Apr; 38(4):461-7. PubMed ID: 12663238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data.
    Kmeid M; Liu X; Ballentine S; Lee H
    Gastroenterology Res; 2021 Apr; 14(2):49-65. PubMed ID: 34007347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease.
    Hernández-Gea V; Campreciós G; Betancourt F; Pérez-Campuzano V; Seijo S; Díaz A; Gallego-Durán R; Olivas P; Orts L; Magaz M; Baiges A; Turon F; Sidorova J; Romero-Gómez M; Lozano JJ; García-Pagán JC
    J Hepatol; 2021 Oct; 75(4):924-934. PubMed ID: 34052252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI.
    Kang JH; Kim DH; Kim SY; Kang HJ; Lee JB; Kim KW; Lee SS; Choi J; Lim YS
    Abdom Radiol (NY); 2021 May; 46(5):1891-1903. PubMed ID: 33095310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis?
    Gioia S; Nardelli S; Ridola L; d'Amati G; Riggio O
    World J Hepatol; 2019 Aug; 11(8):613-618. PubMed ID: 31528244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.